• Publications
  • Influence
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
CONTEXT Large segments of the population at risk for osteoporosis and fracture have not been evaluated, and the usefulness of peripheral measurements for short-term prediction of fracture risk isExpand
  • 1,131
  • 39
  • PDF
Bone mineral density thresholds for pharmacological intervention to prevent fractures.
BACKGROUND Treatment intervention thresholds for prevention of osteoporotic fractures can be derived from reports from the World Health Organization (diagnostic criteria) and National OsteoporosisExpand
  • 565
  • 32
  • PDF
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
BACKGROUND The randomized, double-blind Multiple Outcomes of Raloxifene Evaluation (MORE) trial found that 4 years of raloxifene therapy decreased the incidence of invasive breast cancer amongExpand
  • 594
  • 26
  • PDF
Osteoporosis and Fracture Risk in Women of Different Ethnic Groups
Osteoporosis and 1‐year fracture risk were studied in 197,848 postmenopausal American women from five ethnic groups. Weight explained differences in BMD, except among blacks, who had the highest BMD.Expand
  • 450
  • 26
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
BACKGROUND The effect of raloxifene, a selective estrogen-receptor modulator, on coronary heart disease (CHD) and breast cancer is not established. METHODS We randomly assigned 10,101Expand
  • 324
  • 23
  • PDF
The prevalence of peripheral arterial disease in a defined population.
Because patients with peripheral arterial disease (PAD) may be asymptomatic or may present with atypical symptoms or findings, the true population prevalence of PAD is essentially unknown. We usedExpand
  • 1,039
  • 22
  • PDF
Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies
Background—Vitamin D status has been linked to the risk of cardiovascular disease (CVD). However, the optimal 25-hydroxy-vitamin D (25[OH]-vitamin D) levels for potential cardiovascular healthExpand
  • 484
  • 21
  • PDF
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
Objective: To investigate the association between diabetes and impaired fasting glucose (IFG) and cognition and risk of developing both dementia and mild cognitive impairment (MCI) in older women.Expand
  • 455
  • 19
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
Recent studies have highlighted the relation between erectile dysfunction (ED) and cardiovascular disease. In particular, the role of endothelial dysfunction and nitric oxide in ED andExpand
  • 307
  • 17
Sarcopenia in elderly men and women: the Rancho Bernardo study.
BACKGROUND Sarcopenia risk factors are poorly understood. METHODS This study examines sarcopenia prevalence and risk factors in community-dwelling men (694) and women (1006) aged 55-98 yearsExpand
  • 266
  • 15